p53 gene mutations in gastric and esophageal cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The p53 tumor suppressor gene plays a critical role in preventing cancer.
• Alterations in the p53 gene are common in various human malignancies.

Purpose of the Study:

• To investigate the presence and types of p53 gene mutations in gastric adenocarcinoma and esophageal squamous cell carcinoma.
• To determine if p53 gene mutations are involved in the pathogenesis of these cancers.

Main Methods:

• Analysis of p53 gene exons 5, 6, 7, and 8 using polymerase chain reaction (PCR) and direct nucleotide sequencing.
• Examination of 10 gastric adenocarcinoma and 5 esophageal squamous cell carcinoma samples.

Main Results:

• p53 gene mutations were detected in 50% of gastric cancer cases (5/10) and 80% of esophageal cancer cases (4/5).
• Identified mutations included missense and frame shift mutations in gastric cancer, and missense and splice site mutations in esophageal cancer.
• All identified missense mutations occurred within highly conserved regions of the p53 protein, with specific G to A and G to T transitions.

Conclusions:

• Mutations in the p53 gene are frequent genetic events in the development of gastric adenocarcinoma.
• p53 gene mutations are implicated in the pathogenesis of esophageal squamous cell carcinoma.
• These findings highlight the crucial role of p53 alterations in digestive system cancer development.